Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Study of Analgecine for the Treatment of Neuropathic Pain

NCT02633618 is registered in ClinicalTrials.gov with VanWorld Pharmaceutical (Rugao) Company Limited as lead sponsor.

NCT NCT02633618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02633618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Study of Analgecine for the Treatment of Neuropathic Pain
Lead sponsor
VanWorld Pharmaceutical (Rugao) Company Limited
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2005
Completion date
December 31, 2005
Enrollment
135 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain